These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23953269)

  • 21. Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV.
    Lee TT; Chana G; Gorry PR; Ellett A; Bousman CA; Churchill MJ; Gray LR; Everall IP
    J Neurovirol; 2015 Oct; 21(5):535-43. PubMed ID: 26037113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men.
    Valomon A; Holst SC; Borrello A; Weigend S; Müller T; Berger W; Sommerauer M; Baumann CR; Landolt HP
    Neuropsychopharmacology; 2018 Jun; 43(7):1599-1607. PubMed ID: 29472644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical insights into pharmacogenetics and schizophrenia, part 2.
    Kane JM; Perlis RH; Malhotra AK
    J Clin Psychiatry; 2008 Jun; 69(6):1006-13. PubMed ID: 18683996
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of transcranial direct current stimulation (tDCS) on executive functions: influence of COMT Val/Met polymorphism.
    Plewnia C; Zwissler B; Längst I; Maurer B; Giel K; Krüger R
    Cortex; 2013; 49(7):1801-7. PubMed ID: 23237479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kleptomania treated with tolcapone, a catechol-O-methyl-transferase (COMT) inhibitor.
    Grant JE
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):295-6. PubMed ID: 21062636
    [No Abstract]   [Full Text] [Related]  

  • 27. The COMT val158met polymorphism and brain morphometry in healthy young adults.
    Zinkstok J; Schmitz N; van Amelsvoort T; de Win M; van den Brink W; Baas F; Linszen D
    Neurosci Lett; 2006 Sep; 405(1-2):34-9. PubMed ID: 16857316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine, locus of control, and the exploration-exploitation tradeoff.
    Kayser AS; Mitchell JM; Weinstein D; Frank MJ
    Neuropsychopharmacology; 2015 Jan; 40(2):454-62. PubMed ID: 25074639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Tolcapone De Novo Study Group.
    Hauser RA; Molho E; Shale H; Pedder S; Dorflinger EE
    Mov Disord; 1998 Jul; 13(4):643-7. PubMed ID: 9686768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma.
    Maser T; Rich M; Hayes D; Zhao P; Nagulapally AB; Bond J; Saulnier Sholler G
    Cancer Med; 2017 Jun; 6(6):1341-1352. PubMed ID: 28429453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.
    Ho BC; Wassink TH; O'Leary DS; Sheffield VC; Andreasen NC
    Mol Psychiatry; 2005 Mar; 10(3):229, 287-98. PubMed ID: 15668720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects.
    Pomarol-Clotet E; Fatjó-Vilas M; McKenna PJ; Monté GC; Sarró S; Ortiz-Gil J; Aguirre C; Gomar JJ; Guerrero A; Landin R; Capdevila A; Fañanás L; Salvador R
    Neuroimage; 2010 Nov; 53(3):899-907. PubMed ID: 20398774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
    Laatikainen LM; Sharp T; Bannerman DM; Harrison PJ; Tunbridge EM
    J Psychopharmacol; 2012 Dec; 26(12):1561-8. PubMed ID: 22815336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic modulation of neural response during working memory in healthy individuals: interaction of glucocorticoid receptor and dopaminergic genes.
    El-Hage W; Phillips ML; Radua J; Gohier B; Zelaya FO; Collier DA; Surguladze SA
    Mol Psychiatry; 2013 Feb; 18(2):174-82. PubMed ID: 22083731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.
    Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC
    Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
    Fava M; Rosenbaum JF; Kolsky AR; Alpert JE; Nierenberg AA; Spillmann M; Moore C; Renshaw P; Bottiglieri T; Moroz G; Magni G
    J Clin Psychopharmacol; 1999 Aug; 19(4):329-35. PubMed ID: 10440460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of COMT Genotype on Antero-posterior Cortical Functional Connectivity Underlying Interference Resolution.
    Jaspar M; Manard M; Dideberg V; Bours V; Maquet P; Collette F
    Cereb Cortex; 2016 Feb; 26(2):498-509. PubMed ID: 25205659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [COMT inhibition with tolcapone].
    Nervenarzt; 1996 Jul; 67(7 Suppl Comt-hemmu):1-8. PubMed ID: 9404535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.